Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Origuchi

Showing results (201-210 of 227) with videos related to

Pageof 23
Sort By:
Arthritis Research & Therapy|July 24, 2021
Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritisNaoki Iwamoto, Shuntaro Sato, Shota Kurushima, et al.
Medicine|July 14, 2021
Effect of abatacept treatment on serum osteoclast-related biomarkers in patients with rheumatoid arthritis (RA): A multicenter RA ultrasound prospective cohort in JapanShin-Ya Kawashiri, Yushiro Endo, Ayako Nishino, et al.
BMC Musculoskeletal Disorders|June 2, 2021
Association between serum bone biomarker levels and therapeutic response to abatacept in patients with rheumatoid arthritis (RA): a multicenter, prospective, and observational RA ultrasound cohort study in JapanShin-Ya Kawashiri, Yushiro Endo, Ayako Nishino, et al.
Clinical and Experimental Rheumatology|September 8, 2020
Rheumatoid arthritis patients with low baseline Health Assessment Questionnaire scores have a risk of functional disability progression: a post hoc analysis of a nationwide longitudinal cohort in JapanRemi Sumiyoshi, Toshihiko Hidaka, Tomohiro Koga, et al.
The Journal of Rheumatology|May 3, 2016
Magnetic Resonance Imaging Bone Edema at Enrollment Predicts Rapid Radiographic Progression in Patients with Early RA: Results from the Nagasaki University Early Arthritis CohortYoshikazu Nakashima, Mami Tamai, Junko Kita, et al.
Arthritis Research & Therapy|February 12, 2024
Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry-a historical cohort studyKunihiro Ichinose, Shuntaro Sato, Takashi Igawa, et al.
Internal Medicine (Tokyo, Japan)|July 23, 2019
Gastric Perforation due to Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder during the Treatment of Rheumatoid ArthritisShiho Toyama, Ayuko Takatani, Tomohiro Koga, et al.
Modern Rheumatology|November 9, 2020
Effectiveness and safety of non-tumor necrosis factor inhibitor therapy for anti-human T-cell leukemia virus type 1 antibody-positive rheumatoid arthritisYushiro Endo, Shoichi Fukui, Kunihiko Umekita, et al.
Modern Rheumatology|July 7, 2009
Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese populationNaoki Iwamoto, Atsushi Kawakami, Keita Fujikawa, et al.
Medicine|April 29, 2016
Prognostic Factors Toward Clinically Relevant Radiographic Progression in Patients With Rheumatoid Arthritis in Clinical Practice: A Japanese Multicenter, Prospective Longitudinal Cohort Study for Achieving a Treat-to-Target StrategyTomohiro Koga, Akitomo Okada, Takaaki Fukuda, et al.
Pageof 23

Showing results (201-210 of 227) with videos related to

Sort By:
Pageof 23
Arthritis Research & Therapy|July 24, 2021
Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritisNaoki Iwamoto, Shuntaro Sato, Shota Kurushima, et al.
Medicine|July 14, 2021
Effect of abatacept treatment on serum osteoclast-related biomarkers in patients with rheumatoid arthritis (RA): A multicenter RA ultrasound prospective cohort in JapanShin-Ya Kawashiri, Yushiro Endo, Ayako Nishino, et al.
BMC Musculoskeletal Disorders|June 2, 2021
Association between serum bone biomarker levels and therapeutic response to abatacept in patients with rheumatoid arthritis (RA): a multicenter, prospective, and observational RA ultrasound cohort study in JapanShin-Ya Kawashiri, Yushiro Endo, Ayako Nishino, et al.
Clinical and Experimental Rheumatology|September 8, 2020
Rheumatoid arthritis patients with low baseline Health Assessment Questionnaire scores have a risk of functional disability progression: a post hoc analysis of a nationwide longitudinal cohort in JapanRemi Sumiyoshi, Toshihiko Hidaka, Tomohiro Koga, et al.
The Journal of Rheumatology|May 3, 2016
Magnetic Resonance Imaging Bone Edema at Enrollment Predicts Rapid Radiographic Progression in Patients with Early RA: Results from the Nagasaki University Early Arthritis CohortYoshikazu Nakashima, Mami Tamai, Junko Kita, et al.
Arthritis Research & Therapy|February 12, 2024
Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry-a historical cohort studyKunihiro Ichinose, Shuntaro Sato, Takashi Igawa, et al.
Internal Medicine (Tokyo, Japan)|July 23, 2019
Gastric Perforation due to Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder during the Treatment of Rheumatoid ArthritisShiho Toyama, Ayuko Takatani, Tomohiro Koga, et al.
Modern Rheumatology|November 9, 2020
Effectiveness and safety of non-tumor necrosis factor inhibitor therapy for anti-human T-cell leukemia virus type 1 antibody-positive rheumatoid arthritisYushiro Endo, Shoichi Fukui, Kunihiko Umekita, et al.
Modern Rheumatology|July 7, 2009
Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese populationNaoki Iwamoto, Atsushi Kawakami, Keita Fujikawa, et al.
Medicine|April 29, 2016
Prognostic Factors Toward Clinically Relevant Radiographic Progression in Patients With Rheumatoid Arthritis in Clinical Practice: A Japanese Multicenter, Prospective Longitudinal Cohort Study for Achieving a Treat-to-Target StrategyTomohiro Koga, Akitomo Okada, Takaaki Fukuda, et al.
Pageof 23